The detection and treatment of Plasmodium falciparum malaria: Time for change
In most countries where malaria is endemic, P. falciparum malaria is on the rise. This is primarily due to the spread of drug-resistant strains. Drug resistance is mediated by spontaneous changes in the parasite genome that allow resistant parasites to escape the action of the drugs. The spread of d...
Main Authors: | Nosten F, Ashley E |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2004-01-01
|
Series: | Journal of Postgraduate Medicine |
Subjects: | |
Online Access: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2004;volume=50;issue=1;spage=35;epage=39;aulast=Nosten |
Similar Items
-
Decreased prevalence of <it>Plasmodium falciparum</it> resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar
by: Fröberg Gabrielle, et al.
Published: (2012-09-01) -
Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated <it>falciparum</it> malaria in calabar, Nigeria
by: Meremikwu Martin M, et al.
Published: (2012-12-01) -
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
by: Amaratunga, C., et al.
Published: (2022) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01) -
Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon
by: Mombo-Ngoma Ghyslain, et al.
Published: (2012-07-01)